Home » Authors » Aaron Lorenzo

Articles by Aaron Lorenzo

Biolex Signs Up Centocor In Wide-Ranging Protein Deal

March 22, 2005

By Aaron Lorenzo

Onyx, Bayer Plan To File NDA For Sorafenib On Interim Data

March 22, 2005

By Aaron Lorenzo

Onyx Pharmaceuticals Inc. and Bayer Pharmaceuticals Corp. plan to file for FDA approval of BAY 43-9006, which has been renamed sorafenib, based on interim Phase IIII data from a study in advanced kidney cancer patients. (BioWorld Today)

Onyx, Bayer Plan To File NDA For Sorafenib On Interim Data

March 22, 2005

By Aaron Lorenzo

Onyx Pharmaceuticals Inc. and Bayer Pharmaceuticals Corp. plan to file for FDA approval of BAY 43-9006, which has been renamed sorafenib, based on interim Phase IIII data from a study in advanced kidney cancer patients. (BioWorld Today)

Biolex Signs Up Centocor In Wide-Ranging Protein Deal

March 22, 2005

By Aaron Lorenzo

BIO Ventures Pushes Biotech Involvement In Global Issues

March 21, 2005

By Aaron Lorenzo

BIO Ventures Pushes Biotech Involvement In Global Issues

March 21, 2005

By Aaron Lorenzo

Crawford stands before senate committee seeking confirmation

March 18, 2005

By Aaron Lorenzo

Crawford Stands Before Senate Committee, Begins Confirmation

March 18, 2005

By Aaron Lorenzo

Crawford Stands Before Senate Committee, Begins Confirmation

March 18, 2005

By Aaron Lorenzo

Keryx Receives FDA's Blessing On KRX-101's Pivotal Protocol

March 17, 2005

By Aaron Lorenzo

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...